400776-37-6 Usage
Uses
Used in Pharmaceutical Research and Development:
TERT-BUTYL [6-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE is used as a research compound for the development of new pharmaceuticals. Its unique structure, which includes the carbamate group and the aminoethylpyridinyl group, may offer specific biological activities or interactions with biological targets, making it a candidate for drug discovery and medicinal chemistry.
Used in Chemical Synthesis:
In the chemical industry, TERT-BUTYL [6-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE is used as an intermediate in the synthesis of other organic compounds. Its versatile structure allows for further functionalization and modification, which can lead to the creation of new molecules with desired properties for various applications.
Used in Material Science:
TERT-BUTYL [6-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE may also find applications in material science, where it could be used to develop new materials with specific properties. Its incorporation into polymers or other materials could potentially enhance their performance or introduce new functionalities.
Used in Analytical Chemistry:
As a compound with distinct chemical characteristics, TERT-BUTYL [6-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE can be employed in analytical chemistry for the development of new methods or techniques for detecting, quantifying, or analyzing other substances.
Check Digit Verification of cas no
The CAS Registry Mumber 400776-37-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,0,7,7 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 400776-37:
(8*4)+(7*0)+(6*0)+(5*7)+(4*7)+(3*6)+(2*3)+(1*7)=126
126 % 10 = 6
So 400776-37-6 is a valid CAS Registry Number.
400776-37-6Relevant articles and documents
Benzamide compounds as apo b secretion inhibitors
-
, (2008/06/13)
The present invention relates to compounds of the formula (I) wherein R1 and R2 are each independently lower alkyl lower alkenyl, acyl, amino, lower alkoxy, lower cycloalkyloxy, aryl, aryloxy, sulfooxy, mercapto, sulfo, hydrogen, halogen, nitro, cyano or hydroxy, or may form a ring structure; Q1 is N or CH; L is optionally substituted unsaturated 3 to 10-membered heterocyclic group; X is optionally substituted monocyclic arylene or monocyclic heteroarylene; Y is -(A1)m-(A2)n-(A4)k-; Z is directbond, —CH2-, —NH— or —O—; and R is hydrogen or lower alkyl, or a salt thereof The compounds of the present invention inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B.
